1

EPISODE · May 15, 2026 · 13 MIN

FDA Blocks Melanoma Drug as Makary's Chaos Erodes Patient Trust in Approvals

from 1nessAgency Insights

The FDA in May 2026 blocked approval of a melanoma treatment that extended life for a third of trial participants, a decision that fell during a year of unprecedented regulatory chaos under now-former Commissioner Marty Makary. The denial of RP1, a genetically engineered virus designed to destroy tu

Episode metadata supplied by the publisher feed · Published May 15, 2026

Embed this episode

NOW PLAYING

FDA Blocks Melanoma Drug as Makary's Chaos Erodes Patient Trust in Approvals

0:00 13:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 1nessAgency Insights?

This episode is 13 minutes long.

When was this 1nessAgency Insights episode published?

This episode was published on May 15, 2026.

Can I download this 1nessAgency Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!